The development of a financial toxicity patient‐reported outcome in cancer: The COST measure

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The content for a financial toxicity PROM was developed in 155 patients. The provisional COST measure demonstrated face and content validity as well as internal consistency and should be validated in larger samples.

Leer artículo completoexternamente

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Journals

Cancer

Institutions

University of Chicago

Northwestern University

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.